Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572449

Concept	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31	2018-01-01 to 2018-12-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue	—	—	686,184,000,000 JPY	—	—	—	—	—	—	—	—	579,787,000,000 JPY	—	—
Cost of sales	—	—	266,071,000,000 JPY	—	—	—	—	—	—	—	—	262,847,000,000 JPY	—	—
Gross profit	—	—	420,113,000,000 JPY	—	—	—	—	—	—	—	—	316,940,000,000 JPY	—	—
Other expenses	—	—	3,124,000,000 JPY	—	—	—	—	—	—	—	—	3,212,000,000 JPY	—	—
Operating profit (loss)	—	—	210,597,000,000 JPY	—	—	—	—	—	—	—	—	124,323,000,000 JPY	—	—
Finance costs	—	—	125,000,000 JPY	—	—	—	—	—	—	—	—	111,000,000 JPY	—	—
Profit (loss) before tax	—	—	207,893,000,000 JPY	—	—	—	—	—	—	—	—	121,449,000,000 JPY	—	—
Income tax expense	—	—	50,333,000,000 JPY	—	—	—	—	—	—	—	—	28,370,000,000 JPY	—	—
Profit (loss)	JPY	157,560,000,000 JPY	157,560,000,000 JPY	JPY	JPY	157,560,000,000 JPY	JPY	92,488,000,000 JPY	591,000,000 JPY	JPY	JPY	93,079,000,000 JPY	92,488,000,000 JPY	JPY
Profit (loss) attributable to
Owners of parent	—	—	157,560,000,000 JPY	—	—	—	—	—	—	—	—	92,488,000,000 JPY	—	—
Non-controlling interests	—	—	JPY	—	—	—	—	—	—	—	—	591,000,000 JPY	—	—
Earnings (loss) per share
Basic earnings (loss) per share	—	—	287.84	—	—	—	—	—	—	—	—	169.08	—	—
Diluted earnings (loss) per share	—	—	287.43	—	—	—	—	—	—	—	—	168.80	—	—